Immune-mediated myelopathy following allogeneic stem cell transplantation

International Journal of Hematology

Volumn 84, Issue 3, 2006, Pages 272-275

  Sakai, Miwa ^a   Ohashi, Kazuteru ^a   Ohta, Keiko ^a   Yamashita, Takuya ^a   Akiyama, Hideki ^a   Kisida, Shuji ^a   Kamata, Noriko ^a   Sakamaki, Hisashi ^a  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

Author keywords

Hematopoietic mixed chimerism; Myelopathy; Unrelated bone marrow transplantation

Indexed keywords

BUSULFAN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE;

ACUTE GASTROENTERITIS; ACUTE SINUSITIS; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BONE SCINTISCANNING; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CHIMERA; CLINICAL FEATURE; CORTICOSTEROID THERAPY; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE MEDIATED INJURY; MULTIPLE SCLEROSIS; MYELODYSPLASTIC SYNDROME; NEUROLOGICAL COMPLICATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PNEUMONIA; PROPHYLAXIS; REFRACTORY ANEMIA; SPINAL CORD DISEASE; THROMBOPHLEBITIS;

ADULT; ANTI-INFLAMMATORY AGENTS; CYCLOSPORINE; FEMALE; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; METHYLPREDNISOLONE; MYELODYSPLASTIC SYNDROMES; PANCYTOPENIA; SPINAL CORD DISEASES; STEM CELL TRANSPLANTATION; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS;

EID: 33750338133     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.06060     Document Type: Article

References (15)

1. Saiz A, Graus F. Neurological complications of hematopoietic cell transplantation. Semin Neurol. 2004;24:427-434.
2. Sostak P, Padovan CS, Yousry TA, et al. Prospective evaluation of neurological complications after allogeneic bone marrow transplantation. Neurology. 2003;60:842-848.
3. Padovan CS, Yousry TA, Schleuning M, et al. Neurological and neuroradiological findings in long-term survivors of allogeneic bone marrow transplantation. Ann Neurol. 1998;43:627-633.
4. Matsumoto H, Seki N, Yamamoto T, et al. A case of asymmetric demyelinating neuropathy in a patient with chronic graft-versus-host disease. Rinsho Shinkeigaku. 2005;45:748-753.
5. Sakai M, Ohashi K, Kobayashi T, et al. Meningeal hematopoiesis following radiation myelitis in a hematopoietic stem-cell transplant recipient. Am J Hematol. 2005;79:291-293.
6. Rouah E, Gruber R, Shearer W, et al. Graft-versus-host disease in the central nervous system. A real entity? Am J Clin Pathol. 1998;89:543.
7. Kida A, Ohashi K, Kobayashi T, et al. Incapacitating lower limb pain syndrome in cord blood stem cell transplant recipients with calcineurin inhibitor. Pathol Oncol Res. 2004;10:204-206.
8. Kida A, Ohashi K, Tanaka C, et al. Calcineurin-inhibitor pain syndrome following haematopoietic stem cell transplantation. Br J Haematol. 2004;126:288.
9. Solaro C, Murialdo A, Giunti D, et al. Central and peripheral nervous system complications following allogeneic bone marrow transplantation. Eur J Neurol. 2001;8:77-80.
10. Saito N, Tanaka T, Matsuda S et al. A case of inflammatory demyelinative myelopathy after bone marrow transplantation. Rinsho Shinkeigaku. 2000;40:556-560.
11. Openshaw H, Slatkin NE, Parker PM, Forman SJ. Immune-mediated myelopathy after allogeneic marrow transplantation. Bone Marrow Transplant. 1995;15:633-6.
12. Hickey WF, Kimura H. Graft-vs.-host disease elicits expression of class I and class II histocompatibility antigens and the presence of scattered T lymphocytes in rat central nervous system. Proc Natl Acad Sci U S A. 1987;84:2082-2086.
13. Baron F, Baker JE, Storb R, et al. Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. Blood. 2004;104:2254-2262.
14. Barta A, Batai A, Kelemen E, et al. Immunological importance of chimerism in transplantation: new conditioning protocol in BMT and the development of chimeric state. Hum Immunol. 2000;61:101-110.
15. Sykes M, Nikolic B. Treatment of severe autoimmune disease by stem-cell transplantation. Nature. 2005;435:620-627.